Bloomberg Anywhere Bloomberg Professional About Bloomberg


 
Athenahealth to Supply Software to Wal-Mart Clinics (Update2)

By Tim Mullaney

July 30 (Bloomberg) -- Athenahealth Inc., the Internet health-care company run by President George W. Bush's cousin, won a contract to supply medical-billing software and services to health clinics in Wal-Mart stores.

The deal between Athenahealth and Houston-based RediClinic LLC, which is opening as many as 200 clinics in Wal-Mart stores by 2010, is the second such agreement Watertown, Massachusetts- based Athenahealth has announced this year, Chief Executive Officer Jonathan Bush said in an interview.

Along with a contract to serve 510 clinics in CVS pharmacies, announced in May, the deal will help Athenahealth beat the 30 percent annual sales growth it promised before going public last year, said Bush, 39. Agreements with RediClinic, Wayne State University in Detroit and CVS aren't included in most profit estimates by analysts, Bush added.

``A chain of 500 or 600 stores is a major thing for us,'' Bush said. ``The second quarter will be expensive for us as we lay in infrastructure. The fourth quarter will be better than we thought as we use that infrastructure'' to serve new clients.

Athenahealth, which went public at $18 a share last September, has 12,723 clients who use its services to automate insurance claims. Until the recent contracts, most clients came from small practices, often with 10 or fewer providers.

Large Chains

The deals with the two retail chains ensure Athenahealth will meet Wall Street targets for new customers, Boston-based JMP Securities Inc. analyst Constantine Davides said. Before Wal-Mart's announcement, other large deals promised 3,400 new providers to Athenahealth's client list by early 2009, ahead of his forecast of 3,300 total new clients. Any sales to small practices would make it beat forecasts, he said.

``The momentum is there across all of their business segments,'' said Davides, who recommends Athenahealth and doesn't own the shares.

The company built and manages Web-based software that memorizes payment rules from different insurance companies and helps doctors file reimbursement claims, Bush said.

The company saves doctors money because the average claim gets paid 30 percent faster, and doctors see revenue rise 7 percent because the system catches coding errors that lead to under-billing, Athenahealth said in regulatory filings.

Athenahealth rose 67 cents, or 2.3 percent, to $29.83 at 4:29 p.m. New York time in Nasdaq Stock Market composite trading. The shares have dropped 17 percent this year.

Plan `Has Legs'

The CVS clinics will be using Athenahealth by the end of August, Sean Wieland, a San Francisco-based Piper Jaffray & Co. analyst, wrote in a July 9 report. That's sooner than the company's prediction on May 16 that CVS clinics would go live by year-end. That could push third-quarter sales and profit ahead of Wall Street predictions, he said.

``The retail strategy has legs,'' Weiland said in an interview. The Wal-Mart agreement won't add enough stores initially to raise earnings estimates, said the analyst, who recommends Athenahealth and doesn't own shares.

The RediClinic agreement also includes outlets in 20 supermarkets run by closely held H-E-B in Texas. The accord calls for H-E-B clinics to use Athenahealth's software to manage the clinics' financial affairs and patients' records. The Wal- Mart health centers will use the financial software and a rival company's medical-records service, Bush said.

Athenahealth's revenue depends on how fast Bentonville, Arkansas-based Wal-Mart Stores Inc. and H-E-B add clinics. Both companies' clinics focus on inexpensive care for minor maladies such as colds and ear infections, plus preventive care including physical exams and flu shots, Bush said.

In-store centers also generate less revenue per provider than other clients because they emphasize inexpensive, basic care, Bush added.

Profit margins on contracts with large companies may also be narrower than on deals with small practices, said Todd Weller, an analyst at Stifel, Nicolaus & Co. in Baltimore. He recommends holding Athenahealth and doesn't own stock.

To contact the reporter on this story: Tim Mullaney in New York at Tmullaney1@bloomberg.net.

Last Updated: July 30, 2008 16:36 EDT

Sponsored links